Global and China Choroidal Neovascularization Drug Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Choroidal Neovascularization Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Cleveland BioLabs, Inc

    • Cumberland Pharmaceuticals, Inc

    • Onconova Therapeutics, Inc

    • ProCertus BioPharm Inc

    • Eli Lilly and Company

    • PharmaIN Corporation

    • RedHill Biopharma Ltd

    • Diffusion Pharmaceuticals Inc

    • Soligenix, Inc

    • Cellphire, Inc

    • Chrysalis BioTherapeutics, Inc

    • Pluristem Therapeutics Inc

    • Humanetics Corporation

    • RDD Pharma Ltd

    • GNI Group Ltd

    • Meabco A/S

    • INSYS Therapeutics, Inc

    • RxBio, Inc

    • Neumedicines Inc

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • AVMOC-001

    • BB-3

    • BBT-007

    • DG-3

    • Entolimod

    • EWA-001

    • Others

    Application:

    • Clinic

    • Hospital

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Choroidal Neovascularization Drug Industry Overview

      • 1.1.1 Choroidal Neovascularization Drug Market Scope and Market Segments

      • 1.1.2 Choroidal Neovascularization Drug Industry Characteristics

      • 1.1.3 Global and China Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Choroidal Neovascularization Drug Production Value and Growth Rate (2017-2028)

    • 1.2 Global Choroidal Neovascularization Drug Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 AVMOC-001

      • 1.2.2 BB-3

      • 1.2.3 BBT-007

      • 1.2.4 DG-3

      • 1.2.5 Entolimod

      • 1.2.6 EWA-001

      • 1.2.7 Others

    • 1.3 Global Choroidal Neovascularization Drug Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Clinic

      • 1.3.2 Hospital

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Choroidal Neovascularization Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Choroidal Neovascularization Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Choroidal Neovascularization Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Choroidal Neovascularization Drug Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Choroidal Neovascularization Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Choroidal Neovascularization Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Choroidal Neovascularization Drug Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Choroidal Neovascularization Drug Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Choroidal Neovascularization Drug Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Choroidal Neovascularization Drug Industry Porter's Five Forces Model Analysis

      • 2.2.3 Choroidal Neovascularization Drug Industry PEST Analysis

    • 2.3 Choroidal Neovascularization Drug Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Choroidal Neovascularization Drug Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Choroidal Neovascularization Drug Industry

    Chapter 3 Global and China Choroidal Neovascularization Drug Market, by Manufacturer

    • 3.1 Global and China Choroidal Neovascularization Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Choroidal Neovascularization Drug Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Choroidal Neovascularization Drug Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Choroidal Neovascularization Drug Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Choroidal Neovascularization Drug Market Top 3 Players

    Chapter 4 Global and China Choroidal Neovascularization Drug Market, by Type (2017-2028)

    • 4.1 Choroidal Neovascularization Drug Market Trend, by Type

    • 4.2 Global Choroidal Neovascularization Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Choroidal Neovascularization Drug Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Choroidal Neovascularization Drug Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Choroidal Neovascularization Drug Price Trend, by Type (2017-2028)

    • 4.3 China Choroidal Neovascularization Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Choroidal Neovascularization Drug Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Choroidal Neovascularization Drug Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Choroidal Neovascularization Drug Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Choroidal Neovascularization Drug Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Choroidal Neovascularization Drug Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Choroidal Neovascularization Drug Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Choroidal Neovascularization Drug Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Choroidal Neovascularization Drug Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Choroidal Neovascularization Drug Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Choroidal Neovascularization Drug Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Choroidal Neovascularization Drug Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Choroidal Neovascularization Drug Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Choroidal Neovascularization Drug Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Choroidal Neovascularization Drug Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Choroidal Neovascularization Drug Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Choroidal Neovascularization Drug Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Choroidal Neovascularization Drug Market Analysis

    • 7.1 North America Choroidal Neovascularization Drug Market, by Type

    • 7.2 North America Choroidal Neovascularization Drug Market, by Application

    • 7.3 North America Choroidal Neovascularization Drug Market Analysis and Forecast, by Country

      • 7.3.1 United States Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Choroidal Neovascularization Drug Market Analysis

    • 8.1 Europe Choroidal Neovascularization Drug Market, by Type

    • 8.2 Europe Choroidal Neovascularization Drug Market, by Application

    • 8.3 Europe Choroidal Neovascularization Drug Market Analysis and Forecast, by Country

      • 8.3.1 Germany Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Choroidal Neovascularization Drug Market Analysis

    • 9.1 APAC Choroidal Neovascularization Drug Market, by Type

    • 9.2 APAC Choroidal Neovascularization Drug Market, by Application

    • 9.3 APAC Choroidal Neovascularization Drug Market Analysis and Forecast, by Country

      • 9.3.1 China Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Choroidal Neovascularization Drug Market Analysis

    • 10.1 Latin America, Middle East and Africa Choroidal Neovascularization Drug Market, by Type

    • 10.2 Latin America, Middle East and Africa Choroidal Neovascularization Drug Market, by Application

    • 10.3 Latin America, Middle East and Africa Choroidal Neovascularization Drug Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Choroidal Neovascularization Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Choroidal Neovascularization Drug Company Profiles

      • 11.1 Cleveland BioLabs, Inc

        • 11.1.1 Cleveland BioLabs, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Cleveland BioLabs, Inc Choroidal Neovascularization Drug Product Profiles, Application and Specification

        • 11.1.3 Cleveland BioLabs, Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Cumberland Pharmaceuticals, Inc

        • 11.2.1 Cumberland Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Cumberland Pharmaceuticals, Inc Choroidal Neovascularization Drug Product Profiles, Application and Specification

        • 11.2.3 Cumberland Pharmaceuticals, Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Onconova Therapeutics, Inc

        • 11.3.1 Onconova Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Onconova Therapeutics, Inc Choroidal Neovascularization Drug Product Profiles, Application and Specification

        • 11.3.3 Onconova Therapeutics, Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 ProCertus BioPharm Inc

        • 11.4.1 ProCertus BioPharm Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 ProCertus BioPharm Inc Choroidal Neovascularization Drug Product Profiles, Application and Specification

        • 11.4.3 ProCertus BioPharm Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Eli Lilly and Company

        • 11.5.1 Eli Lilly and Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Eli Lilly and Company Choroidal Neovascularization Drug Product Profiles, Application and Specification

        • 11.5.3 Eli Lilly and Company Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 PharmaIN Corporation

        • 11.6.1 PharmaIN Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 PharmaIN Corporation Choroidal Neovascularization Drug Product Profiles, Application and Specification

        • 11.6.3 PharmaIN Corporation Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 RedHill Biopharma Ltd

        • 11.7.1 RedHill Biopharma Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 RedHill Biopharma Ltd Choroidal Neovascularization Drug Product Profiles, Application and Specification

        • 11.7.3 RedHill Biopharma Ltd Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Diffusion Pharmaceuticals Inc

        • 11.8.1 Diffusion Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Diffusion Pharmaceuticals Inc Choroidal Neovascularization Drug Product Profiles, Application and Specification

        • 11.8.3 Diffusion Pharmaceuticals Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Soligenix, Inc

        • 11.9.1 Soligenix, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Soligenix, Inc Choroidal Neovascularization Drug Product Profiles, Application and Specification

        • 11.9.3 Soligenix, Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Cellphire, Inc

        • 11.10.1 Cellphire, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Cellphire, Inc Choroidal Neovascularization Drug Product Profiles, Application and Specification

        • 11.10.3 Cellphire, Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Chrysalis BioTherapeutics, Inc

        • 11.11.1 Chrysalis BioTherapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Chrysalis BioTherapeutics, Inc Choroidal Neovascularization Drug Product Profiles, Application and Specification

        • 11.11.3 Chrysalis BioTherapeutics, Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Pluristem Therapeutics Inc

        • 11.12.1 Pluristem Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Pluristem Therapeutics Inc Choroidal Neovascularization Drug Product Profiles, Application and Specification

        • 11.12.3 Pluristem Therapeutics Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Humanetics Corporation

        • 11.13.1 Humanetics Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Humanetics Corporation Choroidal Neovascularization Drug Product Profiles, Application and Specification

        • 11.13.3 Humanetics Corporation Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 RDD Pharma Ltd

        • 11.14.1 RDD Pharma Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 RDD Pharma Ltd Choroidal Neovascularization Drug Product Profiles, Application and Specification

        • 11.14.3 RDD Pharma Ltd Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 GNI Group Ltd

        • 11.15.1 GNI Group Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 GNI Group Ltd Choroidal Neovascularization Drug Product Profiles, Application and Specification

        • 11.15.3 GNI Group Ltd Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Meabco A/S

        • 11.16.1 Meabco A/S Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Meabco A/S Choroidal Neovascularization Drug Product Profiles, Application and Specification

        • 11.16.3 Meabco A/S Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 INSYS Therapeutics, Inc

        • 11.17.1 INSYS Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 INSYS Therapeutics, Inc Choroidal Neovascularization Drug Product Profiles, Application and Specification

        • 11.17.3 INSYS Therapeutics, Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 RxBio, Inc

        • 11.18.1 RxBio, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 RxBio, Inc Choroidal Neovascularization Drug Product Profiles, Application and Specification

        • 11.18.3 RxBio, Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.19 Neumedicines Inc

        • 11.19.1 Neumedicines Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.19.2 Neumedicines Inc Choroidal Neovascularization Drug Product Profiles, Application and Specification

        • 11.19.3 Neumedicines Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Choroidal Neovascularization Drug Industry Investment Prospect and Risk Assessment

    • 12.1 Choroidal Neovascularization Drug Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Choroidal Neovascularization Drug Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure China Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Global Choroidal Neovascularization Drug Production Value and Growth Rate (2017-2028)

    • Figure China Choroidal Neovascularization Drug Production Value and Growth Rate (2017-2028)

    • Figure Global Choroidal Neovascularization Drug Market Size and Growth Rate of AVMOC-001 (2017-2028)

    • Figure Global Choroidal Neovascularization Drug Market Size and Growth Rate of BB-3 (2017-2028)

    • Figure Global Choroidal Neovascularization Drug Market Size and Growth Rate of BBT-007 (2017-2028)

    • Figure Global Choroidal Neovascularization Drug Market Size and Growth Rate of DG-3 (2017-2028)

    • Figure Global Choroidal Neovascularization Drug Market Size and Growth Rate of Entolimod (2017-2028)

    • Figure Global Choroidal Neovascularization Drug Market Size and Growth Rate of EWA-001 (2017-2028)

    • Figure Global Choroidal Neovascularization Drug Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Choroidal Neovascularization Drug Market Size and Growth Rate of Clinic (2017-2028)

    • Figure Global Choroidal Neovascularization Drug Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Choroidal Neovascularization Drug Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Choroidal Neovascularization Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Choroidal Neovascularization Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Choroidal Neovascularization Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Choroidal Neovascularization Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Choroidal Neovascularization Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Choroidal Neovascularization Drug Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Choroidal Neovascularization Drug Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Choroidal Neovascularization Drug Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Choroidal Neovascularization Drug Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Choroidal Neovascularization Drug Market Share, by Manufacturer in 2021

    • Figure Global and China Choroidal Neovascularization Drug Market Share, by Manufacturer in 2022

    • Table Global Choroidal Neovascularization Drug Sales Volume, by Type (2017-2028)

    • Table Global Choroidal Neovascularization Drug Sales Volume Share, by Type (2017-2028)

    • Figure Global Choroidal Neovascularization Drug Sales Volume Share, by Type (2017-2028)

    • Table Global Choroidal Neovascularization Drug Sales Value, by Type (2017-2028)

    • Table Global Choroidal Neovascularization Drug Sales Value Share, by Type (2017-2028)

    • Figure Global Choroidal Neovascularization Drug Price Trend, by Type (2017-2028)

    • Table China Choroidal Neovascularization Drug Sales Volume, by Type (2017-2028)

    • Table China Choroidal Neovascularization Drug Sales Volume Share, by Type (2017-2028)

    • Figure China Choroidal Neovascularization Drug Sales Volume Share, by Type (2017-2028)

    • Table China Choroidal Neovascularization Drug Sales Value, by Type (2017-2028)

    • Table China Choroidal Neovascularization Drug Sales Value Share, by Type (2017-2028)

    • Figure China Choroidal Neovascularization Drug Price Trend, by Type (2017-2028)

    • Table Global Choroidal Neovascularization Drug Sales Volume, by Application (2017-2028)

    • Table Global Choroidal Neovascularization Drug Sales Volume Share, by Application (2017-2028)

    • Figure Global Choroidal Neovascularization Drug Sales Volume Share, by Application (2017-2028)

    • Table Global Choroidal Neovascularization Drug Sales Value, by Application (2017-2028)

    • Table Global Choroidal Neovascularization Drug Sales Value Share, by Application (2017-2028)

    • Figure Global Choroidal Neovascularization Drug Sales Value Share, by Application (2017-2028)

    • Table China Choroidal Neovascularization Drug Sales Volume, by Application (2017-2028)

    • Table China Choroidal Neovascularization Drug Sales Volume Share, by Application (2017-2028)

    • Figure China Choroidal Neovascularization Drug Sales Volume Share, by Application (2017-2028)

    • Table China Choroidal Neovascularization Drug Sales Value, by Application (2017-2028)

    • Table China Choroidal Neovascularization Drug Sales Value Share, by Application (2017-2028)

    • Figure China Choroidal Neovascularization Drug Sales Value Share, by Application (2017-2028)

    • Figure China Choroidal Neovascularization Drug Production, Import, Consumption and Export (2017-2022)

    • Figure North America Choroidal Neovascularization Drug Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Choroidal Neovascularization Drug Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Choroidal Neovascularization Drug Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Choroidal Neovascularization Drug Production, Import, Consumption and Export (2017-2022)

    • Table North America Choroidal Neovascularization Drug Sales Volume, by Type (2017-2028)

    • Table North America Choroidal Neovascularization Drug Sales Volume Share, by Type (2017-2028)

    • Figure North America Choroidal Neovascularization Drug Sales Volume Share, by Type (2017-2028)

    • Table North America Choroidal Neovascularization Drug Sales Volume, by Application (2017-2028)

    • Table North America Choroidal Neovascularization Drug Sales Volume Share, by Application (2017-2028)

    • Figure North America Choroidal Neovascularization Drug Sales Volume Share, by Application (2017-2028)

    • Figure United States Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure United States Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Figure Canada Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Table Europe Choroidal Neovascularization Drug Sales Volume, by Type (2017-2028)

    • Table Europe Choroidal Neovascularization Drug Sales Volume Share, by Type (2017-2028)

    • Figure Europe Choroidal Neovascularization Drug Sales Volume Share, by Type (2017-2028)

    • Table Europe Choroidal Neovascularization Drug Sales Volume, by Application (2017-2028)

    • Table Europe Choroidal Neovascularization Drug Sales Volume Share, by Application (2017-2028)

    • Figure Europe Choroidal Neovascularization Drug Sales Volume Share, by Application (2017-2028)

    • Figure Germany Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Figure UK Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure UK Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Figure France Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure France Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Figure Italy Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Figure Spain Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Figure Poland Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Figure Russia Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Table APAC Choroidal Neovascularization Drug Sales Volume, by Type (2017-2028)

    • Table APAC Choroidal Neovascularization Drug Sales Volume Share, by Type (2017-2028)

    • Figure APAC Choroidal Neovascularization Drug Sales Volume Share, by Type (2017-2028)

    • Table APAC Choroidal Neovascularization Drug Sales Volume, by Application (2017-2028)

    • Table APAC Choroidal Neovascularization Drug Sales Volume Share, by Application (2017-2028)

    • Figure APAC Choroidal Neovascularization Drug Sales Volume Share, by Application (2017-2028)

    • Figure China Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure China Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Figure Japan Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Figure India Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure India Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Choroidal Neovascularization Drug Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Choroidal Neovascularization Drug Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Choroidal Neovascularization Drug Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Choroidal Neovascularization Drug Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Choroidal Neovascularization Drug Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Choroidal Neovascularization Drug Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Choroidal Neovascularization Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Choroidal Neovascularization Drug Sales Value and Growth Rate (2017-2028)

    • Table Cleveland BioLabs, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cleveland BioLabs, Inc Product Profiles, Application and Specification

    • Table Cleveland BioLabs, Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cumberland Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cumberland Pharmaceuticals, Inc Product Profiles, Application and Specification

    • Table Cumberland Pharmaceuticals, Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Onconova Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Onconova Therapeutics, Inc Product Profiles, Application and Specification

    • Table Onconova Therapeutics, Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table ProCertus BioPharm Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table ProCertus BioPharm Inc Product Profiles, Application and Specification

    • Table ProCertus BioPharm Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly and Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly and Company Product Profiles, Application and Specification

    • Table Eli Lilly and Company Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table PharmaIN Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table PharmaIN Corporation Product Profiles, Application and Specification

    • Table PharmaIN Corporation Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table RedHill Biopharma Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table RedHill Biopharma Ltd Product Profiles, Application and Specification

    • Table RedHill Biopharma Ltd Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Diffusion Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Diffusion Pharmaceuticals Inc Product Profiles, Application and Specification

    • Table Diffusion Pharmaceuticals Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Soligenix, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Soligenix, Inc Product Profiles, Application and Specification

    • Table Soligenix, Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cellphire, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cellphire, Inc Product Profiles, Application and Specification

    • Table Cellphire, Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Chrysalis BioTherapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Chrysalis BioTherapeutics, Inc Product Profiles, Application and Specification

    • Table Chrysalis BioTherapeutics, Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pluristem Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pluristem Therapeutics Inc Product Profiles, Application and Specification

    • Table Pluristem Therapeutics Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Humanetics Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Humanetics Corporation Product Profiles, Application and Specification

    • Table Humanetics Corporation Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table RDD Pharma Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table RDD Pharma Ltd Product Profiles, Application and Specification

    • Table RDD Pharma Ltd Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GNI Group Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GNI Group Ltd Product Profiles, Application and Specification

    • Table GNI Group Ltd Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Meabco A/S Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Meabco A/S Product Profiles, Application and Specification

    • Table Meabco A/S Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table INSYS Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table INSYS Therapeutics, Inc Product Profiles, Application and Specification

    • Table INSYS Therapeutics, Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table RxBio, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table RxBio, Inc Product Profiles, Application and Specification

    • Table RxBio, Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Neumedicines Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Neumedicines Inc Product Profiles, Application and Specification

    • Table Neumedicines Inc Choroidal Neovascularization Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.